Aarey Drugs & Pharmaceuticals Management
Management criteria checks 4/4
Aarey Drugs & Pharmaceuticals' CEO is Mihir Ghatalia, appointed in Dec 2009, has a tenure of 14.42 years. total yearly compensation is ₹1.05M, comprised of 57.1% salary and 42.9% bonuses, including company stock and options. directly owns 16.67% of the company’s shares, worth ₹251.80M. The average tenure of the management team and the board of directors is 4.3 years and 4.1 years respectively.
Key information
Mihir Ghatalia
Chief executive officer
₹1.1m
Total compensation
| CEO salary percentage | 57.1% |
| CEO tenure | 14.4yrs |
| CEO ownership | 16.7% |
| Management average tenure | 4.3yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹29m |
| Sep 30 2023 | n/a | n/a | ₹24m |
| Jun 30 2023 | n/a | n/a | ₹37m |
| Mar 31 2023 | ₹1m | ₹600k | ₹38m |
| Dec 31 2022 | n/a | n/a | ₹27m |
| Sep 30 2022 | n/a | n/a | ₹41m |
| Jun 30 2022 | n/a | n/a | ₹48m |
| Mar 31 2022 | ₹2m | ₹600k | ₹66m |
| Dec 31 2021 | n/a | n/a | ₹87m |
| Sep 30 2021 | n/a | n/a | ₹85m |
| Jun 30 2021 | n/a | n/a | ₹77m |
| Mar 31 2021 | ₹1m | ₹602k | ₹65m |
| Dec 31 2020 | n/a | n/a | ₹61m |
| Sep 30 2020 | n/a | n/a | ₹58m |
| Jun 30 2020 | n/a | n/a | ₹51m |
| Mar 31 2020 | ₹1m | ₹600k | ₹58m |
| Dec 31 2019 | n/a | n/a | ₹55m |
| Sep 30 2019 | n/a | n/a | ₹57m |
| Jun 30 2019 | n/a | n/a | ₹65m |
| Mar 31 2019 | ₹2m | ₹600k | ₹65m |
| Dec 31 2018 | n/a | n/a | ₹66m |
| Sep 30 2018 | n/a | n/a | ₹69m |
| Jun 30 2018 | n/a | n/a | ₹64m |
| Mar 31 2018 | ₹300k | ₹300k | ₹62m |
Compensation vs Market: Mihir's total compensation ($USD12.59K) is below average for companies of similar size in the Indian market ($USD39.30K).
Compensation vs Earnings: Mihir's compensation has been consistent with company performance over the past year.
CEO
Mihir Ghatalia (40 yo)
14.4yrs
Tenure
₹1,050,975
Compensation
Mr. Mihir Rajesh Ghatalia, B.E., serves as an Executive Director at Worth Investment & Trading Company Limited. He has been the Managing Director at Aarey Drugs & Pharmaceuticals Ltd. since December 29, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 14.4yrs | ₹1.05m | 16.67% ₹ 251.8m | |
| Executive Director | 3.8yrs | ₹777.59k | no data | |
| Chief Financial Officer | 3.3yrs | no data | no data | |
| Chief Accountant | 26.3yrs | no data | no data | |
| Company Secretary & Compliance Officer | 4.3yrs | ₹429.23k | no data |
4.3yrs
Average Tenure
40yo
Average Age
Experienced Management: 524412's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 19.8yrs | ₹1.05m | 16.67% ₹ 251.8m | |
| Executive Director | 3.8yrs | ₹777.59k | no data | |
| Non-Executive Independent Director | 4.3yrs | no data | no data | |
| Non-Executive Director | less than a year | no data | 14.27% ₹ 215.6m | |
| Non-Executive Independent Director | 15.9yrs | no data | 1.6% ₹ 24.2m | |
| Independent Non Executive Director | 3.8yrs | no data | no data |
4.1yrs
Average Tenure
47.5yo
Average Age
Experienced Board: 524412's board of directors are considered experienced (4.1 years average tenure).